DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Novartis (NYSE: NVS)



company name or ticker
Company Photos
(Click to zoom)

3 Top Stocks for Obamacare Lovers

Love Obamacare? These stocks are right up your alley.

3 Little-Known Biotechs Working On Potential Blockbusters

These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.

5 Freakishly Expensive Cancer Drugs

Prices for cancer medications are soaring.

7 of the Most Audacious 'Moonshot' Projects From Google, Amazon and Facebook

Ligand Pharmaceuticals: Biotech's Jack Of All Trades

Is It Time for GlaxoSmithKline plc to Change Management?

GlaxoSmithKline's share price has stagnated under CEO Andrew Witty. Is it time for a change?

Juno: Trying To Justify A $5.5B Valuation For A Year-Old Company

Is This The Biggest Threat to Isis Pharmaceuticals Stock?

Isis Pharmaceuticals has garnered a massive premium based on the potential of its antisense drug pipeline. With numerous companies entering the rare disease field, though, Isis' drugs might face stiff competition. So are investors being overly optimistic?

Novartis Reports Positive Data on Psoriasis Drug Cosentyx - Analyst Blog

11 Promising New Drugs Expected to Make Billions in Sales

See More Articles...